Navigation Links
Merz, Inc. Announces Promotion of Katrina Church to Vice President, Chief Compliance Officer
Date:7/9/2012

GREENSBORO, N.C., July 9, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Katrina Church has been promoted to vice president, chief compliance officer, effective July 1, 2012. Church will be responsible for providing strategic and operational leadership relating to compliance issues.

"Katrina brings extensive experience and a wealth of legal knowledge in pharmaceutical regulatory compliance to her new role," said Bill Humphries, president and chief executive officer of Merz, Inc. "Merz, Inc. is committed to a tight set of core values that foster a positive, productive and unified work environment. As a company, we do what is right even when it is not easy. Katrina plays a vital role in ensuring that we uphold the highest standards and values in this dynamic regulatory environment. We look forward to working with her on the many compliance requirements facing pharmaceutical companies today."

Church joined Merz in November 2009 and has more than 20 years of legal experience in various areas, including private legal practice and in-house corporate counsel positions. Prior to joining Merz, she was employed by Connetics, Inc. where she served as general counsel. Following the acquisition of Connetics by Stiefel Laboratories, Inc., in 2006, she provided legal consulting services to Stiefel.

Church graduated Magna Cum Laude from Duke University and obtained her Juris Doctor from the New York University School of Law. She is admitted to the Bar in California, certified in Healthcare Compliance and is a member of the American Corporate Counsel Association, American Health Lawyers Association, Health Care Compliance Association, and the Society of Corporate Compliance and Ethics. Church will remain at Merz, Inc. headquarters in Greensboro, N.C.

About Merz, Inc. Merz, Inc. develops and commercializes products for Merz Pharma Group. Areas of therapeutic focus include Neurology, Physiatry, Derma
'/>"/>

SOURCE Merz, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Akorn, Inc. Announces Second Quarter 2012 Earnings Release And Conference Call Information
2. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
3. Aoxing Pharmaceutical Company Announces Management Change
4. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
5. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
6. ULURU Inc. Announces Completion Of $2.2mil Convertible Debt Offering
7. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
8. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
9. MicroVention Announces First Patient Enrollment In Clinical Trial To Compare Coiling Technologies For Treating Brain Aneurysms
10. Omron Healthcare Announces New Pedometers
11. Improved Maintenance and Control of Electronic Health Records. ICAP Patent Brokerage Announces for Auction Patented Techniques for Improved Patient Control and Selective Access to Electronic Medical Records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014   Decision Resources Group finds that ... chronic kidney disease non-dialysis (CKD-ND) patients are not ... In addition, one-year persistency is similar between Amgen,s ... key findings from the report entitled ... Stimulating Agents in Late Stage Chronic Kidney Disease ...
(Date:9/30/2014)... Ind. , Sept. 30, 2014  The orthopedic specialists ... the nation,s No. 6 orthopedic group by US News ... Active Adults," a series of free, public seminars to ... all over the world come to see the knee ... procedures are now available at Munster Specialty Surgery Center. ...
(Date:9/30/2014)... In 2011, approximately 5.1 million people in ... pain relievers (e.g. opioids). 1 Clinical treatments for ... the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. The ... developing and improving care management programs, according to ... Therapeutics LLC (Prime). Cost trends ...
Breaking Medicine Technology:Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3"Knee Pain Solutions for Active Adults" Complimentary Seminars Open to the Public 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3
... , LITTLE FALLS, N.J., Dec. 2 ... the results for its first quarter ended October 31, 2009 on ... to discuss the results at 11:00 AM ET. Participating in ... President and CEO; Seth R. Segel, Executive Vice President; Craig A. ...
... , , CENTENNIAL, Colo., Dec. 2 ... bone and soft tissue allografts for use in surgical procedures ... substitutes, today announced its sponsorship of a truly iconic symbol ... Life float in the January 1, 2010 Tournament of Roses ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3
(Date:9/30/2014)... Health Day Reporter TUESDAY, ... who are overweight or obese when diagnosed appear to ... weight-related cancer, new research suggests. , , The finding ... only the potential for developing other cancers associated with ... who reported being overweight or obese prior to diagnosis ...
(Date:9/30/2014)... Symposia will convene the first conference of its 2014-2015 ... Series on "The Modes of Action of Vaccine ... the conclusion of the Grand Challenges Meeting for that ... Keystone Symposia Global Health Series, supported by the Bill ... awards for 36 investigators from developing countries to attend. ...
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth County’s ... medical specialty practice through a unique partnership with an ... located within the company’s Shrewsbury location and will be ... of American Heart Center, P.C., a highly regarded practice ... Integrated Medicine Alliance patients top notch cardiovascular care without ...
(Date:9/30/2014)... team has been awarded a three-year $1.7 million ... to develop new imaging technologies and data analysis ... large networks of neurons in the brain interact ... researchers identify the precise interactions between millions of ... speaking, and alterations in these interactions that may ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
Breaking Medicine News(10 mins):Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2
... released software program will let health authorities at the ... speeding the detection of new cases and the implementation ... was developed by a team of epidemiologists and computer ... (MIDAS), an international program supported by the National Institutes ...
... Cover Election, Customer Service and Other Work Life Topics ... That Counter Recent ... those,surveyed in the 2007 Annual Work+Life Fit Reality Check believe the ... offer and individuals to have more work life flexibility.,The telephone survey ...
... Avani to Represent Dermatology Products Featuring Invisicare(R), ... Inc. (OTC,Bulletin Board: SKVI) / (Website: ... has signed a marketing agreement with Avani,International ... it was granted a comprehensive patent in ...
... Dec. 6 Insmed Inc. (Nasdaq:,INSM), a developer of ... at the IBC 5th Annual Global Follow-On Biologics,Conference on ... The conference, to be held at the Hyatt Regency ... through Tuesday, December,11th, and will bring together corporate, regulatory, ...
... Health, Inc. (Amex: OPK ),today reported that the ... of wet age-related macular degeneration (wet,AMD), was named one ... III,clinical trials during the third quarter of 2007. The ... to Watch report issued by Thomson,Scientific Inc. Thomson,s industry ...
... you get for the nut,that has everything, including more than ... talking therapy doll?, You can at once give a ... it, their own personal and portable psychotherapist. The,Ask Doctor Chuck ... could,earn you the undying gratitude of the rest of your ...
Cached Medicine News:Health News:New software to aid early detection of infectious disease outbreaks 2Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 2Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 3Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 4Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 5Health News:Skinvisible Signs Marketing Agreement for India 2Health News:Skinvisible Signs Marketing Agreement for India 3Health News:Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference 2Health News:OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials 2Health News:OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials 3Health News:OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials 4Health News:The Cure for Holiday Stress 2
The fat loss formula's key ingredient of 2.0% aminophylline works by penetrating deep into the skin where it causes the body fat cells to shrink, resulting in up to 2 inches of body fat loss....
... VelaSmooth is the first ... device with the revolutionary elos ... Radio Frequency and Infrared Light ... with suction to reduce the ...
... was designed with the physician, staff ... you the best economy exam room ... does not skimp on patient comfort. ... can easily position patients so that ...
The Salt A-Peel™ microdermabrasion combines, positive air pressure, pure salt, ultrasound and the application of rich anti oxidant products to deliver a remarkable 'The Salt A-Peel' anti ageing...
Medicine Products: